Vabysmo

Medicinal product

(Invented) name

Vabysmo

Active substance (s)

Faricimabas

Strength

120 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA09, faricimab

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2022-09-15

Date of renewal

Documents

Vabysmo mokomoji medziaga pacientams.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1 ml
Faricimabas	120 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109439	95545	1095545	flakonas	0,24 ml N1 (+ filtro adata)		Receptinis	EU/1/22/1683/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-09-15	Registruotas